From CBS 2 Chicago, a reminder that the development of more sophisticated stem cell transplant therapies is proceeding in parallel with first generation stem cell medicine that uses the patient's own cells: "Phil has volunteered for a procedure he hopes will reverse the damage to his heart and prevent or delay congestive heart failure down the road. ... It's called the Osiris trial. Healthy stem cells from an adult donor's bone marrow are given through an ordinary IV line. Because they're in an early stage of development, Phil's body won't reject them. They'll be able to find their way to his heart. ... The hope is they can differentiate, or change into functional heart muscle, and repair and regenerate the heart tissue that's been damaged by the heart attack."
Link: http://cbs2chicago.com/health/local_story_107203343.html